All.Can is committed to efficiency in cancer care. By working with all stakeholders, we aim to achieve our goal: better health outcomes for cancer patients. This is why we focus on finding, supporting and sharing evidence-based and measurable ways to improve cancer care.
Every year, almost 9,000 women [1] undergo a cone biopsy to treat precancerous lesions. Precancerous lesions are abnormal cells in the cervix that can develop into cervical cancer. They are detected through cervical screening. A cone biopsy is preceded by a colposcopy – a closer examination of the cervix. In…
All.Can Belgium is committed to efficiency in cancer care. But what exactly does that mean?
The All.Can Cancer Efficiency Metrics Study (2022) provides an answer to this question. Eight key metrics emerge from this comprehensive international study. These metrics can be used to assess and improve efficiency in cancer care.
All.Can Belgium is committed to efficiency in cancer care. But what exactly does that mean?
The All.Can Cancer Efficiency Metrics Study (2022) provides an answer to this question. Eight key metrics emerge from this comprehensive international study. These metrics can be used to assess and improve efficiency in cancer care.
All.Can Belgium uses these eight parameters to set up and evaluate projects. For example, our ‘Get Checked Early’ campaign emphasises the importance of timely diagnosis and therefore ties in with the first parameter (time to diagnosis).
Every year, almost 9,000 women [1] undergo a cone biopsy to treat precancerous lesions. Precancerous lesions are abnormal cells in the cervix that can develop into cervical cancer. They are detected through cervical screening. A cone biopsy is preceded by a colposcopy – a closer examination of the cervix. In…
Anal cancer is rare, almost always linked to HPV, and in many cases preventable — if we detect precancerous lesions in time. In an in-depth interview, Dr. Magali Surmont (UZ Brussels) shares how Belgium is taking action against anal cancer. She points to three key areas where we can truly…
Since January 2025, cervical cancer screening for women aged 30 and over has been carried out differently. The smear is now first tested for the presence of human papillomavirus (HPV), and only then, depending on the result of that first test, are the cells examined. There is a good reason…
All.Can Belgium is pleased to announce the publication of its new white paper: "Measuring what matters: Towards a shared framework for clinically meaningful endpoints in curative oncology". The paper addresses a timely and complex question at the heart of modern cancer care: how can we ensure that the endpoints used…
On December 4, 2025, All.Can Belgium brought together policymakers, clinicians, scientists, patients, and healthcare system stakeholders at the Federal Parliament for a roundtable discussion on innovation in cancer care. The meeting, chaired by federal Member of Parliament and pharmacist Kathleen Depoorter and moderated by Hanne Decoutere, built on the report…
Sweden is well on its way to control the spread of human papillomavirus (HPV) and by doing so, virtually eliminate cervical cancer by 2027. If successful, it would be a historic first: a country eradicating a cancer altogether. How? By doubling down on both HPV vaccination and cervical screening —…
On 16 January 2026, All.Can Belgium convened a multi-stakeholder event in Brussels focused on one central question: how do we define, generate and use endpoints in curative oncology that are truly clinically meaningful for patients, clinicians and decision-makers?
Many women with gynecological cancer feel alone and ashamed. Gynca's wants to change that. The non-profit organization gives them a voice and stands up for their interests. Chair Anne De Middelaer looks back on the past five years — and ahead to the future. “There is still a lot of…
Detecting lung cancer earlier through targeted screening — and thereby improving chances of survival — is the goal of the ZORALCS study, currently underway in six municipalities around Antwerp. People between the ages of 55 and 74 who smoke or used to smoke are being offered a free CT scan.…
